PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2111555
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2111555
Medical Radiation Shielding Market size was valued at US$ 1,360.2 Million in 2025, expanding at a CAGR of 5.1% from 2026 to 2033.
Medical Radiation Shielding Market involves materials, equipment, and engineered products intended to shield patients, medical personnel, technologists, and the environment against any potential harmful exposure to ionizing radiation emitted by diagnostic or therapeutic equipment. Major products within the market include lead-based and non-lead based shielding products, radiation shielding glass, doors, curtains, mobile shields, walls, panels, and garments employed in radiology, X-ray, CT, nuclear medicine, interventional, and radiation therapy rooms. This segment of the medical imaging market is largely driven by increasing applications of radiation for diagnostic and therapeutic applications as well as the need for occupational safety. According to the International Atomic Energy Agency (IAEA), there are over 4 billion radiologic exams carried out each year worldwide. Increasing CT, interventional and radiotherapy practices have led many hospitals to install special shielding, while environmental issues are promoting the use of tungsten, bismuth, barium and polymer-based lead-free shielding products.
Medical Radiation Shielding Market- Market Dynamics
Expansion of Radiation-Based Diagnostic and Interventional Procedures
The growing use of X-ray, CT, fluoroscopy, nuclear medicine, and image guided procedures is driving up the demand for dedicated shielding structures. The IAEA estimated the number of annual medical radiological procedures at 4.2 billion, 40 million nuclear medicine procedures and 6 million radiation therapy procedures worldwide. The trend towards more advanced imaging modalities such as CT, CBCT, PET/CT and interventional procedures is leading to the necessity of more accurately designed shields. In 2026, Lead Glass Pro increased its shielding production capacity and purchased new CNC milling centers, along with laser-cutting and press-brake machinery, to produce more customized shielding elements. These investments suggest that healthcare facilities increasingly require custom-made and precision-manufactured shields, not standardized ones.
The Global Medical Radiation Shielding Market is segmented on the basis of Product Type, Material, Solution, End User, and Region.
In relation to various products, X-ray Shielding is still one of the biggest applications, since there is extensive usage of traditional radiography and fluoroscopy in hospitals, clinics, and diagnostic centers. CT Shielding requires better shielding due to its higher intensity of radiation and extensive use of improved CT machines. MRI Shielding is more concerned with electromagnetic interference and not ionizing radiation, which means it uses copper or steel chambers that provide additional shielding. In case of Nuclear Medicine Shielding, the focus is on gamma ray emitting radionuclides, whereas Radiation Therapy Shielding makes use of advanced shielding structures.
In terms of Material, Lead continues to be extensively utilized due to its excellent ability to attenuate and its thin dimensions. Lead alloys possess superior shielding properties with added features such as enhanced flexibility or lightness, which help in developing advanced medical uses. Concrete is preferred for fixed structure shielding purposes for facilities of CT, nuclear medicine, and radiotherapy, owing to its availability and load bearing nature. Tungsten has a high shielding density in limited spaces. On the other hand, there are various alloys that do not use lead but include bismuth, tungsten, tin, antimony, and polymer.
Medical Radiation Shielding Market- Geographical Insights
The North American market is one of the major revenue-generators for the medical radiation shielding, due to widespread installation of CT scans, X-ray machines, nuclear medicine and radiation therapy devices in hospitals and outpatient imaging centers. The area is favored by developed healthcare infrastructure, strict radiation protection laws, frequent replacement of imaging equipment and high adoption rate of advanced intervention techniques. The United States continues to play the leading role, with continuous developments in the construction of hospitals, ambulatory imaging centers and radiotherapy facilities creating a constant demand for shielding products.
The Asia-Pacific region is projected to grow at the highest rate among all regions due to growing infrastructure for the healthcare sector, growing diagnostic imaging capabilities, and investment in cancer centers. Countries in this region such as China, India, Japan, South Korea, and other Southeast Asian nations are increasingly providing CT scans, fluoroscopy, nuclear medicine, and radiation therapy. The International Atomic Energy Agency (IAEA) reports that over 60 percent of the total number of radiation therapy devices in the world are found in developed nations, indicating the infrastructure deficit that the healthcare sector is trying to overcome.
The market for radiation shielding in healthcare is somewhat fragmented and competitive based on performance, weight of materials, custom engineering, installation capabilities, ergonomics, and regulatory compliance. MAVIG specializes in integrated radiation protection solutions that consist of ceiling mounted shields, mobile barriers, protective curtains, and personal protection equipment. Its Image Safely product is designed specifically for interventional applications requiring enhanced protection without interfering with patient care process. Burlington Medical's niche is in light-weight custom-engineered radiation-protection apparel and lead-free materials while MarShield is focused on customization of architectural shields, lead-lined doors, windows, cabinets, mobile barriers, and solutions for medical facilities. Nelco Worldwide, GPS, Ray-Bar Engineering, A&L Shielding, and Veritas Medical Solutions are strong players in architectural shielding projects. On the other hand, ETS-Lindgren capitalizes on its electromagnetic-shielding technology.
In May 2026, NELCO Worldwide expanded its collaboration with Oncology Systems Limited (OSL) to support radiotherapy projects across Europe. The partnership strengthens NELCO's regional presence while combining OSL's local relationships with NELCO's radiation-shielding design and project-delivery capabilities, demonstrating the industry's shift toward localized turnkey shielding solutions.